Potent P2Y6 receptor mediated contractions in human cerebral arteries

BMC Pharmacology

Volumn 3, Issue , 2003, Pages

  Malmsjö, Malin ^a   Hou, Mingyan ^a   Pendergast, William ^b   Erlinge, David ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cerebral arteries; Human; P2X receptor; P2Y receptor; Purine; Pyrimidine; Vasoconstriction

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; MESSENGER RNA; PURINE ANTAGONIST; PURINE P2X1 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ADOLESCENT; ADULT; ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; CORONARY ARTERY; DRUG TARGETING; ENDOTHELIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISOMETRICS; OMENTUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1642346773     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-3-4     Document Type: Article

References (36)

1. Burnstock G Purinergic signaling and vascular cell proliferation and death Arterioscler Thromb Vasc Biol 2002, 22:364-73
2. Burnstock G Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction J Anat 1999, 194:335-42
3. Ralevic V and Burnstock G Receptors for purines and pyrimidines Pharmacol Rev 1998, 50:413-92
4. Shirasawa Y, White RP and Robertson JT Mechanisms of the contractile effect induced by uridine 5-triphosphate in canine cerebral arteries Stroke 1983, 14:347-55
5. Keppler D, Rudigier J and Decker K Enzymic determination of uracil nucleotides in tissues Anal Biochem 1970, 38:105-14
6. Urquilla PR Prolonged contraction of isolated human and canine cerebral arteries induced by uridine 5′-triphosphate Stroke 1978, 9:133-6
7. Miyagi Y, Kobayashi S, Nishimura J, Fukui M and Kanaide H Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation Br J Pharmacol 1996, 118:847-56
8. Evans RJ, Surprenant A and North RA P2X receptors In: The P2 nucleotide receptors (Edited by: Turner JT, Weisman GA, Fedan JS) Totowa, NJ: Human Press Inc 1998, 109-134
9. Harden TK, Nicholas RA, Schlater JB, Lazarowski ER and Boyer JL Pharmacological selectivities of molecularly defined subtypes of P2Y receptors In: The P2 nucleotide receptors (Edited by: Turner JT, Weisman GA, Fedan JS) Totowa, NJ: Human Press Inc 1998, 109-134
10. Hansen MA, Dutton JL, Balcar VJ, Barden JA and Bennett MR P2X (purinergic) receptor distributions in rat blood vessels J Auton Nerv Syst 1999, 75:147-55
11. Lewis CJ and Evans RJ Comparison of P2X receptors in rat mesenteric, basilar and septal (coronary) arteries J Auton Nerv Syst 2000, 81:69-74
12. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A and Buell G A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP Nature 1994, 371:516-9
13. Léon C, Hechler B, Vial C, Leray C, Cazenave JP and Gachet C The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells FEBS Lett 1997, 403:26-30
14. Palmer RK, Boyer JL, Schachter JB, Nicholas RA and Harden TK Agonist action of adenosine triphosphates at the human P2Y1 receptor Mol Pharmacol 1998, 54:1118-23
15. Nicholas RA, Watt WC, Lazarowski ER, Li Q and Harden K Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor Mol Pharmacol 1996, 50:224-9
16. Gordon JL Extracellular ATP: effects, sources and fate Biochem J 1986, 233:309-19
17. Hou M, Harden TK, Kuhn CM, Baldetorp B, Lazarowski E, Pendergast W, Moller S, Edvinsson L and Erlinge D UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors Am J Physiol Heart Circ Physiol 2002, 282:H784-92
18. Lazarowski ER, Watt WC, Stutts MJ, Brown HA, Boucher RC and Harden TK Enzymatic synthesis of UTP gamma S, a potent hydrolysis resistant agonist of P2U-purinoceptors Br J Pharmacol 1996, 117:203-9
19. Hamel E, Assumel-Lurdin C, Edvinsson L, Fage D and MacKenzie ET Neuronal versus endothelial origin of vasoactive acetylcholine in pial vessels Brain Res 1987, 420:391-6
20. Högestatt ED, Andersson KE and Edvinsson L Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels Acta Physiol Scand 1983, 117:49-61
21. Communi D, Pirotton S, Parmentier M and Boeynaems JM Cloning and functional expression of a human uridine nucleotide receptor J Biol Chem 1995, 270:30849-52
22. Communi D, Parmentier M and Boeynaems JM Cloning, functional expression and tissue distribution of the human P2Y6 receptor Biochem Biophys Res Commun 1996, 222:303-8
23. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L, Weisman GA, Boucher RC and Turner JT Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy Proc Natl Acad Sci U S A 1994, 91:3275-9
24. Valera S, Talabot F, Evans RJ, Gos A, Antonarakis SE, Morris MA and Buell GN Characterization and chromosomal localization of a human P2X receptor from the urinary bladder Receptors Channels 1995, 3:283-9
25. Léon C, Vial C, Cazenave JP and Gachet C Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor Gene 1996, 171:295-7
26. Malmsjö M, Hou M, Harden TK, Pendergast W, Pantev E, Edvinsson L and Erlinge D Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5′-O-thiodiphosphate and uridine 5′-O-3-thiotriphosphate J Pharmacol Exp Ther 2000, 293:755-60
27. Malmsjö M, Adner M, Harden TK, Pendergast W, Edvinsson L and Erlinge D The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery Br J Pharmacol 2000, 131:51-6
28. Shirahase H, Usui H, Manabe K, Kurahashi K and Fujiwara M Endothelium-dependent contraction and -independent relaxation induced by adenine nucleotides and nucleoside in the canine basilar artery J Pharmacol Exp Ther 1988, 247:1152-7
29. Sima B, Macdonald L, Marton LS, Weir B and Zhang J Effect of P2-purinoceptor antagonists on hemolysate-induced and adenosine 5′-triphosphate-induced contractions of dog basilar artery in vitro Neurosurgery 1996, 39:815-21
30. Sima B, Weir BK, Macdonald RL and Zhang H Extracellular nucleotide-induced [Ca2+]i elevation in rat basilar smooth muscle cells Stroke 1997, 28:2053-8
31. Toda N, Okunishi H, Taniyama K and Miyazaki M Responses to adenine nucleotides and related compounds of isolated dog cerebral, coronary and mesenteric arteries Blood Vessels 1982, 19:226-36
32. Lewis CJ, Ennion SJ and Evans RJ P2 purinoceptor-mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors J Physiol 2000, 527(Pt 2):315-24
33. Bo X, Karoon P, Nori SL, Bardini M and Burnstock G P2X purinoceptors in postmortem human cerebral arteries J Cardiovasc Pharmacol 1998, 31:794-9
34. Wihlborg A-K, Malmsjö M, Eyjolfsson A, Gustafsson R, Jacobson K and Erlinge D Extracellular nucleotides induce vasodilatation in human arteries via prostaglandin, nitric oxide and endothelium-dependent hyperpolarizing factor Br J Pharmacol
35. Hardebo JE, Kahrstrom J, Owman C and Salford LG Endothelium-dependent relaxation by uridine tri- and diphosphate in isolated human pial vessels Blood Vessels 1987, 24:150-5
36. Lazarowski ER, Homolya L, Boucher RC and Harden TK Identification of an ecto-nucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists J Biol Chem 1997, 272:20402-7